Phase 2Recruiting
Pilot Study on Evaluating the Geroprotective Effect of Metformin (AGE-M)
A Phase II Exploratory Clinical Study Investigating the Geroprotective Effect of Metformin in Middle-aged and Elderly People
- Sponsor
- Xuanwu Hospital, Beijing (Academic or other)
- Enrolment
- 130 planned
- Conditions
- Metformin; Aging
- Interventions
- Metformin Hydrochloride tablet; Placebo
- Ages
- adults, older adults
- Registry
- NCT06459310
From the registry
The objective of this research is to assess the efficacy of oral metformin in mitigating the aging process in middle-aged and elderly males, to pinpoint sensitive indicators of human senescence, and to offer innovative frameworks and scientific insights for pharmaceutical interventions in aging.
Primary outcomes
- Composite the efficacy of metformin in intervening aging